ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

India COVID crisis raises pressure on US to waive vaccine patents

Emerging countries push for a WTO-rule exemption amid surging infections

A coronavirus patient receives treatment at a hospital in New Delhi: India's flood of new infections has caused a severe shortage of oxygen for medical use.   © Reuters

VIENNA/WASHINGTON -- Facing pressure amid renewed surges in coronavirus cases in India and other emerging countries, the U.S. has begun considering loosening vaccine patent protections to increase global access to the shots.

Many emerging economies are calling for a temporary exemption to the World Trade Organization's vaccine patent rules in order to increase vaccine production. But pharmaceutical and biotech companies have pushed back against the idea, warning it could put sensitive technologies in the hands of overseas rivals.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more